Law firm launches Invacare probe

Monday, June 3, 2013

ELYRIA, Ohio – Faruqi & Faruqi, a law firm that specializes in securities litigation, is investigating potential securities fraud at Invacare, according to a press release. The investigation centers on whether Invacare violated federal securities laws by issuing false or misleading statements regarding the company’s noncompliance with Food and Drug Administration (FDA) guidelines, as well as Current Good Manufacturing Practices (CGMP) provisions. Of particular focus is whether Invacare failed to disclose to investors a series of FDA warnings, known as Form 483s, detailing compliance violations at its two major manufacturing facilities, the release noted. Faruqi & Faruqiu is encouraging investors who bought stock or options between July 22, 2010, and July 7, 2011, to contact the firm to discuss their legal options.